Acetazolamide Quantitative, Serum or Plasma
Also known as: ACETAZOLAM
Use
The Acetazolamide Quantitative, Serum or Plasma test is used to measure the concentration of acetazolamide in the serum or plasma. Acetazolamide is a medication primarily used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, and heart failure. This test helps in monitoring the therapeutic levels of the drug, adjusting dosages, and ensuring patient safety by avoiding potential toxicity.
Special Instructions
Separate from cells ASAP or within 2 hours of collection. The test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Limitations
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration. The performance of the test has not been validated for all possible clinical settings.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 3300-1
- 3300-1
Result Turnaround Time
5-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
ARUP standard transport tube
Collection Instructions
Plain red, pink (K2EDTA), or lavender (K2EDTA) tubes. Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Refrigerated. Also acceptable: Room temperature or frozen.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 month |
| Refrigerated | 1 month |
| Frozen | 1 month |